DrugPatentWatch Database Preview
METHYCLOTHIAZIDE AND DESERPIDINE Drug Profile
When do Methyclothiazide And Deserpidine patents expire, and when can generic versions of Methyclothiazide And Deserpidine launch?
The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for METHYCLOTHIAZIDE AND DESERPIDINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | METHYCLOTHIAZIDE AND DESERPIDINE at DailyMed |
US Patents and Regulatory Information for METHYCLOTHIAZIDE AND DESERPIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | METHYCLOTHIAZIDE AND DESERPIDINE | deserpidine; methyclothiazide | TABLET;ORAL | 088486-001 | Aug 10, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Watson Labs | METHYCLOTHIAZIDE AND DESERPIDINE | deserpidine; methyclothiazide | TABLET;ORAL | 088452-001 | Aug 10, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
